Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 775.55 Billion JPY | -10.2% |
| 2023 | 865.32 Billion JPY | 2.45% |
| 2022 | 844.59 Billion JPY | 7.52% |
| 2021 | 785.54 Billion JPY | 22.55% |
| 2020 | 640.99 Billion JPY | 30.91% |
| 2019 | 489.64 Billion JPY | -8.38% |
| 2018 | 534.4 Billion JPY | -5.21% |
| 2017 | 563.8 Billion JPY | -8.52% |
| 2016 | 616.33 Billion JPY | -14.91% |
| 2015 | 724.29 Billion JPY | 4.04% |
| 2014 | 696.19 Billion JPY | -13.87% |
| 2013 | 808.33 Billion JPY | -11.99% |
| 2012 | 918.49 Billion JPY | 1.65% |
| 2011 | 903.58 Billion JPY | -3.4% |
| 2010 | 935.33 Billion JPY | -0.23% |
| 2009 | 937.53 Billion JPY | -5.34% |
| 2008 | 990.47 Billion JPY | 32.61% |
| 2007 | 746.92 Billion JPY | 10.52% |
| 2006 | 675.81 Billion JPY | 11.9% |
| 2005 | 603.95 Billion JPY | 40.68% |
| 2004 | 429.32 Billion JPY | 12.26% |
| 2003 | 382.45 Billion JPY | 6.75% |
| 2002 | 358.25 Billion JPY | -8.13% |
| 2001 | 389.96 Billion JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 790.23 Billion JPY | 1.14% |
| 2024 Q1 | 781.34 Billion JPY | -9.7% |
| 2024 FY | 775.55 Billion JPY | -10.37% |
| 2024 Q4 | 775.55 Billion JPY | 7.99% |
| 2024 Q3 | 718.19 Billion JPY | -9.12% |
| 2023 Q2 | 842.02 Billion JPY | -1.09% |
| 2023 FY | 865.32 Billion JPY | 2.45% |
| 2023 Q4 | 865.32 Billion JPY | 9.95% |
| 2023 Q1 | 851.31 Billion JPY | 0.79% |
| 2023 Q3 | 787.02 Billion JPY | -6.53% |
| 2022 FY | 844.59 Billion JPY | 7.52% |
| 2022 Q1 | 743.22 Billion JPY | -5.09% |
| 2022 Q3 | 812.67 Billion JPY | 10.11% |
| 2022 Q2 | 738.07 Billion JPY | -0.69% |
| 2022 Q4 | 844.59 Billion JPY | 3.93% |
| 2021 Q2 | 745.95 Billion JPY | 1.2% |
| 2021 Q1 | 737.12 Billion JPY | 14.51% |
| 2021 FY | 785.54 Billion JPY | 22.55% |
| 2021 Q4 | 783.11 Billion JPY | 4.5% |
| 2021 Q3 | 749.38 Billion JPY | 0.46% |
| 2020 Q3 | 590.64 Billion JPY | -1.4% |
| 2020 Q1 | 507.1 Billion JPY | 3.57% |
| 2020 Q4 | 643.7 Billion JPY | 8.98% |
| 2020 Q2 | 599.02 Billion JPY | 18.13% |
| 2020 FY | 640.99 Billion JPY | 30.91% |
| 2019 Q4 | 489.64 Billion JPY | 1.18% |
| 2019 FY | 489.64 Billion JPY | -8.38% |
| 2019 Q2 | 496.92 Billion JPY | -11.4% |
| 2019 Q1 | 560.85 Billion JPY | 4.95% |
| 2019 Q3 | 483.92 Billion JPY | -2.62% |
| 2018 Q2 | 541.26 Billion JPY | -4.02% |
| 2018 Q1 | 563.94 Billion JPY | 0.03% |
| 2018 FY | 534.4 Billion JPY | -5.21% |
| 2018 Q4 | 534.4 Billion JPY | -0.68% |
| 2018 Q3 | 538.05 Billion JPY | -0.59% |
| 2017 Q3 | 576.34 Billion JPY | 5.64% |
| 2017 Q2 | 545.55 Billion JPY | -8.44% |
| 2017 Q1 | 595.86 Billion JPY | -2.38% |
| 2017 FY | 563.8 Billion JPY | -8.52% |
| 2017 Q4 | 563.8 Billion JPY | -2.18% |
| 2016 Q1 | 721.03 Billion JPY | -0.45% |
| 2016 Q4 | 610.39 Billion JPY | -10.7% |
| 2016 Q2 | 664.41 Billion JPY | -7.85% |
| 2016 FY | 616.33 Billion JPY | -14.91% |
| 2016 Q3 | 683.5 Billion JPY | 2.87% |
| 2015 Q1 | 673.43 Billion JPY | -3.27% |
| 2015 FY | 724.29 Billion JPY | 4.04% |
| 2015 Q2 | 634.05 Billion JPY | -5.85% |
| 2015 Q3 | 661.37 Billion JPY | 4.31% |
| 2015 Q4 | 724.29 Billion JPY | 9.51% |
| 2014 Q4 | 696.19 Billion JPY | -0.36% |
| 2014 FY | 696.19 Billion JPY | -13.87% |
| 2014 Q3 | 698.73 Billion JPY | 1.24% |
| 2014 Q2 | 690.14 Billion JPY | -4.73% |
| 2014 Q1 | 724.4 Billion JPY | -10.38% |
| 2013 Q2 | 817.36 Billion JPY | -8.54% |
| 2013 Q1 | 893.69 Billion JPY | -2.7% |
| 2013 FY | 808.33 Billion JPY | -11.99% |
| 2013 Q4 | 808.33 Billion JPY | -1.95% |
| 2013 Q3 | 824.38 Billion JPY | 0.86% |
| 2012 Q2 | 905.22 Billion JPY | -4.34% |
| 2012 Q3 | 885.8 Billion JPY | -2.15% |
| 2012 Q4 | 918.49 Billion JPY | 3.69% |
| 2012 FY | 918.49 Billion JPY | 1.65% |
| 2012 Q1 | 946.34 Billion JPY | 4.73% |
| 2011 FY | 903.58 Billion JPY | -3.4% |
| 2011 Q2 | 882.69 Billion JPY | -3.12% |
| 2011 Q3 | 889.2 Billion JPY | 0.74% |
| 2011 Q4 | 903.58 Billion JPY | 1.62% |
| 2011 Q1 | 911.14 Billion JPY | -2.59% |
| 2010 Q1 | 918.84 Billion JPY | -1.99% |
| 2010 FY | 935.33 Billion JPY | -0.23% |
| 2010 Q3 | 913.94 Billion JPY | -2.07% |
| 2010 Q4 | 935.33 Billion JPY | 2.34% |
| 2010 Q2 | 933.3 Billion JPY | 1.57% |
| 2009 Q3 | 953.82 Billion JPY | -1.03% |
| 2009 FY | 937.53 Billion JPY | -5.34% |
| 2009 Q2 | 963.72 Billion JPY | 0.0% |
| 2009 Q4 | 937.53 Billion JPY | -1.71% |
| 2008 FY | 990.47 Billion JPY | 32.61% |
| 2007 FY | 746.92 Billion JPY | 10.52% |
| 2006 FY | 675.81 Billion JPY | 11.9% |
| 2005 FY | 603.95 Billion JPY | 40.68% |
| 2004 FY | 429.32 Billion JPY | 12.26% |
| 2003 FY | 382.45 Billion JPY | 6.75% |
| 2002 FY | 358.25 Billion JPY | -8.13% |
| 2001 FY | 389.96 Billion JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -33004516.477% |
| Ansell Limited | 1.32 Billion USD | -58216.67% |
| Ansell Limited | 1.33 Billion USD | -58107.52% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -613775.89% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -82228486.09% |
| Psykey, Inc. | 2.47 Million USD | -31347961.595% |
| ConvaTec Group Plc | 2.01 Billion USD | -38329.175% |
| ConvaTec Group Plc | 2.02 Billion USD | -38274.913% |
| Encision Inc. | 1.98 Million USD | -39091105.1% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -25507624.276% |
| Innovative MedTech Inc. | 6.13 Million USD | -12641739.408% |
| LifePoint, Inc. | 2.45 Million USD | -31601513.418% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -7617589.814% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -22810400.0% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -25508933.086% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -99900457.624% |
| SmileDirectClub, Inc. | 982.26 Million USD | -78856.306% |
| Sector 10, Inc. | 9.84 Million USD | -7877231.488% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -57106.865% |
| SheerVision, Inc. | 1.43 Million USD | -54181496.657% |
| United Health Products, Inc. | 1.99 Million USD | -38799691.282% |
| Vasamed, Inc. | 1 Million USD | -77146721.844% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -20407764.147% |
| Yubo International Biotech Limited | 2.91 Million USD | -26615453.46% |